Amalgamated Bank Ab Cellera Biologics Inc. Transaction History

Amalgamated Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$7.31 - $11.18 $32,931 - $50,365	-4,505 Reduced 15.23%	25,070 $189,000
Q4 2022 Feb 10, 2023	BUY	$9.48 - $14.52 $2,009 - $3,078	212 Added 0.72%	29,575 $300,000
Q3 2022 Nov 09, 2022	BUY	$9.2 - $13.68 $3,449 - $5,130	375 Added 1.29%	29,363 $290,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $165,811 - $308,722	28,988 New	28,988 $309,000

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.